Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
暂无分享,去创建一个
[1] D. Spyker,et al. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction , 1983, Antimicrobial Agents and Chemotherapy.
[2] E. Burgess,et al. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis , 1983, Antimicrobial Agents and Chemotherapy.
[3] J. Humphries,et al. Peritonitis in continuous ambulatory peritoneal dialysis patients. , 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] M. Brier,et al. Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis , 1983, Clinical pharmacology and therapeutics.
[5] P. Somani,et al. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis , 1982, Clinical pharmacology and therapeutics.
[6] E. Swabb,et al. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects , 1982, Antimicrobial Agents and Chemotherapy.
[7] T. Golper,et al. Stability of antimicrobial agents in peritoneal dialysate , 1982, Antimicrobial Agents and Chemotherapy.
[8] G. Bodey,et al. Comparative in vitro study of SQ26,776 , 1982, Antimicrobial Agents and Chemotherapy.
[9] K. Bush,et al. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria , 1982, Antimicrobial Agents and Chemotherapy.
[10] K. Iseki,et al. Captopril (SQ 14225) clearance during hemodialysis treatment. , 1981, Clinical nephrology.
[11] O. Cars,et al. A microtechnique for the determination of antibiotics in muscle. , 1981, The Journal of antimicrobial chemotherapy.
[12] M. Sussman,et al. Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis. , 1981, Clinical nephrology.
[13] F. Luft,et al. Moxalactam pharmacokinetics during hemodialysis , 1981, Antimicrobial Agents and Chemotherapy.
[14] C. Comty,et al. Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis , 1981, Antimicrobial Agents and Chemotherapy.
[15] P. J. Wills,et al. Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease , 1981, Antimicrobial Agents and Chemotherapy.
[16] J. Bower,et al. Peritoneal dialysis during peritonitis. , 1981, Kidney international.
[17] B. Meyers,et al. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis , 1981, Antimicrobial Agents and Chemotherapy.
[18] R. Ogilvie,et al. Cefoxitin disposition during peritoneal dialysis , 1981, Antimicrobial Agents and Chemotherapy.
[19] J. S. Wells,et al. Monobactams—monocyclic β -lactam antibiotics produced by bacteria , 1981 .
[20] E. Swabb,et al. Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects. , 1981, The Journal of antimicrobial chemotherapy.
[21] J. S. Wells,et al. Monobactams--monocyclic beta-lactam antibiotics produced by bacteria. , 1981, The Journal of antimicrobial chemotherapy.
[22] R. Wise,et al. SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents. , 1981, The Journal of antimicrobial chemotherapy.
[23] D. Perrier,et al. Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability , 1978, Clinical pharmacology and therapeutics.
[24] V. Andriole. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. , 1978, The Journal of infectious diseases.
[25] J. Fillastre,et al. Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. , 1978, The Journal of antimicrobial chemotherapy.
[26] H. Imanaka,et al. NOCARDICIN A, A NEW MONOCYCLIC β-LACTAM ANTIBIOTIC , 1976 .
[27] J. Anderson,et al. Letter: Brittle diabetes. , 1974, Lancet.